Residual vessel length on magnetic resonance angiography identifies poor responders to alteplase in acute middle cerebral artery occlusion patients: exploratory analysis of the Japan Alteplase Clinical Trial II.
Hirano
Teruyuki
T
Department of Neurology, Faculty of Life Sciences, Kumamoto University, Kumamoto, Japan. terry07@kumamoto-u.ac.jp
Sasaki
Makoto
M
Mori
Etsuro
E
Minematsu
Kazuo
K
Nakagawara
Jyoji
J
Yamaguchi
Takenori
T
D000367:Age Factors; D000368:Aged; D001808:Blood Vessels / Q000473:pathology; D002986:Clinical Trials as Topic; D005260:Female; D006801:Humans; D020244:Infarction, Middle Cerebral Artery / Q000188:drug therapy* / Q000473:pathology*; D007275:Injections, Intravenous; D007564:Japan / Q000453:epidemiology; D018810:Magnetic Resonance Angiography; D008297:Male; D010960:Plasminogen Activators / Q000008:administration & dosage / Q000627:therapeutic use*; D011446:Prospective Studies; D012044:Regression Analysis; D012737:Sex Factors; D010959:Tissue Plasminogen Activator / Q000008:administration & dosage / Q000627:therapeutic use*; D016896:Treatment Outcome
D010960:Plasminogen Activators; D010959:Tissue Plasminogen Activator